Identification of Biomarkers in Cervical Mucus
Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Jan 10, 2025
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on studying cervical mucus, a fluid produced in the female reproductive system that plays an important role in fertility. The researchers want to learn more about the specific characteristics of cervical mucus, especially how it changes during a woman’s menstrual cycle. By doing this, they hope to identify certain markers that could help diagnose or predict issues related to infertility in women.
Women between the ages of 18 and 45 who are either healthy and have had no trouble getting pregnant or those experiencing unexplained infertility may be eligible to participate. Participants will undergo regular monitoring of their menstrual cycles and provide samples of cervical mucus over time. This study is not yet recruiting participants, but it aims to provide valuable insights into how cervical mucus can impact fertility. If you or someone you know fits the eligibility criteria, this could be an important opportunity to contribute to understanding female reproductive health.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • HEALTHY CONTROL
- • Women of 18-45 years old,
- • Use of the Billings Ovulation Method® for at least three months in the last three years
- • Proven fertility
- • STUDY COHORT
- • Women of 18-45 years old,
- • Women affected by unexplained infertility
- Exclusion Criteria:
- • Virgo women
- • Women incapable of understanding and wanting
- • Women who have had sexual intercourse in the two days prior to cervical mucus sampling
- • Pregnancy, exclusive breastfeeding
- • Amenorrhea
- • Gynecological hormone ongoing therapies or suspended for less than three months
- • Cervico -vaginal infections
- • Psychiatric pathologies
- • Untreated/decompensated endocrine-metabolic disorders
- • Coagulopathies and renal pathologies under dialysis treatment
- • Refusal of informed consent
- • Previous, current or suspected oncological pathology
About Fondazione Policlinico Universitario Agostino Gemelli Irccs
Fondazione Policlinico Universitario Agostino Gemelli IRCCS is a leading research and healthcare institution based in Rome, Italy, renowned for its commitment to advancing medical science and improving patient care. As a prominent academic medical center affiliated with the Catholic University of the Sacred Heart, it integrates clinical practice, education, and research, fostering innovation in various fields of medicine. The foundation conducts a wide range of clinical trials aimed at developing new therapies and enhancing treatment protocols, with a focus on translational research that bridges the gap between laboratory discoveries and patient care. Its multidisciplinary approach and dedication to high ethical standards position it as a key player in the landscape of clinical research and healthcare improvement in Italy and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported